Visually Impaired OLder people's Exercise programme for falls prevenTion (VIOLET): a feasibility study protocol by Skelton, Dawn A. et al.
Visually Impaired OLder people’s
Exercise programme for falls
prevenTion (VIOLET): a feasibility
study protocol
Dawn A Skelton,1 Cathy Bailey,2 Denise Howel,3 Mima Cattan,4 Vincent Deary,5
Dot Coe,6 Lex D de Jong,7 Sheena Gawler,6 Joanne Gray,8 Rosy Lampitt,9
Jennifer Wilkinson,9 Nicola Adams6
To cite: Skelton DA, Bailey C,
Howel D, et al. Visually
Impaired OLder people’s
Exercise programme for falls
prevenTion (VIOLET):
a feasibility study protocol.
BMJ Open 2016;6:e011996.
doi:10.1136/bmjopen-2016-
011996
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2016-011996).
Received 21 March 2016
Revised 3 July 2016
Accepted 5 July 2016
For numbered affiliations see
end of article.
Correspondence to
Dr Cathy Bailey; Catherine.
bailey@northumbria.ac.uk
ABSTRACT
Introduction: In the UK, 1 in 5 people aged 75 and
over live with sight loss. Visually impaired older people
(VIOP) have an above average incidence of falls and
1.3–1.9 times more likely to experience hip fractures,
than the general population. Older people with eye
diseases are ∼3 times more likely than those with
good vision, to limit activities due to fear of falling.
This feasibility study aims to adapt the group-based
Falls Management Exercise (FaME) programme to the
needs of VIOP and carry out an external pilot trial to
inform the design of a future definitive randomised
controlled trial.
Methods and design: A UK based 2-centre mixed
methods, randomised, feasibility study will be
conducted over 28 months. Stakeholder panels,
including VIOP, will make recommendations for
adaptations to an existing exercise programme (FaME),
to meet the needs of VIOP, promoting uptake and
adherence, while retaining required effective
components of the exercise programme. 80 VIOP aged
60 and over, living at home, ambulant with or without
a walking aid, will be recruited in Newcastle (n=40) and
Glasgow (n=40) through National Health Service (NHS)
Trusts and third sector partners. Participants
randomised into the intervention arm will receive the
adapted FaME programme. Participants randomised
into the control arm will continue with usual activity.
Outcomes are, recruitment rate, adherence and
validated measures including fear of falling and quality
of life. Postintervention in-depth qualitative interviews
will be conducted with a purposive sample of VIOP
(N=10). Postural stability instructors will be
interviewed, before trial-specific training and following
the intervention.
Ethics and dissemination: Ethics approval was
secured through the National Research Ethics Service
(NRES) Committee North East, Newcastle and North
Tyneside 2. Glasgow Caledonian University was
approved as a non-NHS site with local ethics approval.
Findings will be disseminated through peer-reviewed
journals, national and international conferences.
Trial registration number: ISRCTN16949845.
BACKGROUND
One in eight people in the UK aged over 75
and one in three aged over 90, live with sig-
niﬁcant sight loss.1 Visually impaired older
people (VIOP) are more likely to move into
residential settings than sighted peers, be
physically dependent and have poorer
quality of life.2–4 Vision impairment (VI) is
associated with a loss of function in activities
of daily living.5 6 A UK report by Visibility7
found that older people are highly likely to
avoid activity because of their VI. Anxiety
and depression are also common in those
with VI and this also leads to reduced
activity.8
Falls are seldom due to a single cause.9 10
Poor vision has been identiﬁed as being par-
ticularly related to the recurrence of falls11
although VI is not independently associated
with higher incidence of falls.12 Visual acuity,
contrast sensitivity and visual ﬁeld defects
have been identiﬁed as important features of
poor vision and VI related to falls risk.13 14
VIOP have a 1.7 times higher risk of falling
than the general population and report
Strengths and limitations of this study
▪ Addresses falls prevention intervention in an
often excluded population, older people with
visual impairment, with a known efficacious falls
prevention intervention (Falls Management
Exercise—FaME).
▪ Working with older people with visual impair-
ment to adapt FaME to their needs, a programme
so far only tested on sighted people.
▪ As a feasibility study run in two study sites, it
does not have the power to show effectiveness
but will allow informed planning for a definitive
randomised controlled trial in the future if shown
to be feasible.
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more contact with their general practitioner (GP) and
more hospital and nursing home admissions than their
peers who do not have VI.14 15 Estimates of the number
of falls attributed to VI suggest that 8% of falls-related
hospital admissions are likely to occur in visually
impaired people, accounting for 21% of the total cost of
treating accidental falls.15 These estimates may hide wide
geographical variation and falls attributed to VI are
underestimated, as reasons for falling may not be known
or recorded and costs to GPs may not be included in
treatment costs.15
Falls in older people cost the National Health Service
(NHS) ∼4.6 million per day.16 Evidence suggests multi-
factorial falls intervention programmes are effective in
reducing falls among older people and include tackling
underlying health problems, initiating strength and
balance training, offering home modiﬁcations and
checking footwear.17 18 One study has considered both
occupational therapy and physiotherapy intervention in
people with visual impairment and saw a reduction in
falls.19 In the UK, the National Service Framework for
Older People20 suggested that falls should be addressed
in NHS. In 2004, the National Institute for Health and
Care Excellence (NICE) guidelines on prevention and
assessment of falls in older people21 suggested that by
2005, all NHS boards in the UK should provide a falls
service. A survey in 200822 highlighted that just half of
participating falls clinics in the UK, assessed for VI but
there was little information about how to modify falls
prevention programmes for VIOP.
Fear of falling (FoF), with or without a fall, is also
common in VIOP and can lead to a cycle of restricting
daily activity and mobility with loss of conﬁdence, dimin-
ishing physical and mental assets, reduced social partici-
pation and overall quality of life.23–25 FoF is a broad
term encompassing fear, anxiety, impaired perception of
ability to walk safely without falling and loss of conﬁ-
dence.26 FoF is a signiﬁcant predictor of a future fall.27
It is clear, in therapists and participants, that there is a
distinction between proper caution around activity and
an overcautious/fear-avoidance cycle that perpetuates
disability.28 A recent review of FoF29 suggests that FoF
contributes to falls risk on top of actual gait or balance
problems. Exercise can reduce FoF,30 at least in the
short term, however FoF can also be a barrier to uptake
of exercise programmes. Research suggests that per-
ceived risk, stigma, lack of awareness among health pro-
fessionals, lack of appropriate supporting materials and
FoF may be barriers to exercise attendance.7 23 Enabling
factors could include peer acceptability, appropriate sup-
porting material with demonstration, sensitive explan-
ation, carer involvement and individually tailored
interventions.7 23
The study draws on the learning from a number of pre-
vious studies, including the Falls Management Exercise
(FaME)31 programme, the visually impaired person
(VIP) trial (prevention of falls in people aged ≥75 with
severe visual impairment),19 and the recently completed
VIP2UK pilot study (Application Reference Number:
UKCRN ID 10883) adapted from the Otago home-based
programme to increase adherence in VIOP.23 It is known
that adherence to the Otago programme in VIOP was sig-
niﬁcantly lower than older people without signiﬁcant
visual impairment (only 18% VIOP completed all home
exercise sessions over a year period19) and this may have
been due to lack of conﬁdence exercising at home
without supervision. Although the VIP2UK study showed
better compliance to exercise with additional support
strategies (mentors, extra phone calls, audio exercise
clips and embedding exercises into daily living) being in
place but still low compared with previous studies of the
Otago programme in general older adults.23
The FaME group-based programme was chosen as the
preferred exercise intervention as a recent Royal College
of Physicians report showed that 54% of falls services
have trained postural stability instructors (PSIs) deliver-
ing the FaME programme in groups.32 A 6-month pro-
gramme of FaME exercises has also been shown to
signiﬁcantly increase habitual physical activity in older
people recruited through primary care, by 15 min of
moderate to vigorous activity a day even at 12 months
postintervention, as well as reducing falls.33
This paper describes the protocol for the Visually
Impaired OLder People’s Exercise programme for falls
prevenTion (VIOLET), feasibility study (V.1.1, 2
February 2015). The study was funded by the National
Institute for Health Research (NIHR) Public Health
Research (PHR) Programme.
The rationale for the study is to provide an opportun-
ity for VIOP to contribute to the adaptation of a group-
based falls prevention programme that is prevalent in
falls services across the UK. This should facilitate an
acceptable, feasible and appealing intervention that will
improve uptake and adherence to a known effective
intervention.
AIM OF THE STUDY
To conduct a mixed-methods feasibility and pilot study
to inform the design and conduct of a future deﬁnitive
multicentre randomised controlled trial (RCT) of an
adapted group-based exercise programme to prevent
falls and reduce FoF among VIOP.
OBJECTIVES
Feasibility study
1. Explore VIOP’s ability to act as lay partners in a study
to develop a condition-appropriate intervention.
2. Explore VIOP’s reasons for participating/not partici-
pating in the exercise programme and for those who
participate, their experiences of the feasibility study
procedures.
3. Identify the feasibility, delivery and acceptability of
candidate outcome measures for the future RCT
(validated questionnaires/interview methods to
measure FoF, activity avoidance, well-being/quality of
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life, anxiety, depression, loneliness and the number
of falls) and VIOP centred/identiﬁed outcome
measures.
4. Explore the capacity to deliver the adapted exercise
programme.
5. Examine delivery (ﬁdelity) and compliance of the
exercise intervention.
Randomised control pilot
6. Assess recruitment of older people with visual impair-
ment (VIOP) and their willingness to be randomised
into the adapted falls prevention exercise
programme.
7. Test the methodology and to provide outcome data
to inform sample size calculations for a deﬁnitive
RCT.
8. Assess the feasibility of collecting service-use data for
an economic evaluation of the intervention in a
future RCT.
9. Develop a manualised intervention protocol and
training package for a deﬁnitive RCT.
STUDY GOVERNANCE
A Trial Management Group (TMG), including the chief
investigator, study statistician, trial manager and database
manager is responsible for overseeing the progress of
this feasibility study. The day-to-day management is coor-
dinated by Dr Rosy Lampitt, Trial Manager, Newcastle
Clinical Trials Unit. A Trial Oversight Committee
(TOC), with an independent Chair and including exter-
nal members independent of the study, fulﬁls the com-
bined role and responsibilities of a Data Monitoring and
Ethics Committee (DMEC) and Trial Steering
Committee (TSC). The TOC acts as the oversight body
for this study on behalf of the sponsor and funder, safe-
guards the interests of study participants, assesses the
safety and efﬁcacy of the intervention, and monitors
the overall conduct of the study. The TOC also protects
the validity and credibility of the study, and provides
advice through its independent Chair to the TMG,
sponsor and funder on all aspects of the study.
METHODS
Study design
This is a two-centre randomised feasibility study of an
adapted exercise programme for VIOP with embedded
qualitative evaluation. The comparison is between a
12-week exercise programme (1-hour session per week
plus two home-based sessions progressing from 30 min
to 2 hours) and usual activities. Stakeholder panels of
VIOP meeting at the two sites will discuss what adapta-
tions to the FaME programme31 are desirable and neces-
sary to make the programme more accessible to VIOP.
Study setting, recruitment and screening
Figure 1 provides a consort diagram of planned ﬂow of
participants for this study.
Eighty community-living VIOP aged 60 and over will
be recruited (40 from each of the two study sites). In
Newcastle, participants will be recruited from the Royal
Victoria Inﬁrmary’s (RVI) Eye Centre and from
Newcastle Society for the Blind’s (NSBP) membership.
In Glasgow, participants will be recruited from the
Glasgow Caledonian University Low Vision Clinic and
from the vision charity, Visibility Glasgow. Invitation
letters and information about the study in large print or
audio recorded (in the participant’s preferred format)
will be sent out through the Low Vision Units and the
organisations for visually impaired people or handed
out by the low vision specialist/activities coordinators.
The participant information will be designed in consult-
ation with the stakeholder panel and checked to ensure
that it meets Royal National Institute for the Blind
(RNIB) standards in terms of suitability for those with
visual impairment.
VIOP who express interest in participating in the study
will be screened for eligibility by a researcher over the
telephone or on site, based on the inclusion/exclusion
criteria below. Once informed consent has been gained,
the participant’s GP will be approached, via a letter
explaining the inclusion and exclusion criteria, to make
a judgement regarding the medical ﬁtness of the partici-
pant to take part in the exercise intervention. A screen-
ing log will be completed by the research staff. It will
document the outcome of the screening contact and
record any reasons for screen failure. For participants
who decline participation, the screening log will docu-
ment any reasons available for non-participation. The
log will also ensure potential participants are only
approached once.
Inclusion criteria
Participants will be aged 60 years and over and attending
a low vision clinic and/or are members of organisations
for the visually impaired. They will also be living in their
own home, able to walk indoors without the help of
another person but may use a walking aid, such as a
stick, able to walk outdoors but may need the help of
another person and/or a walking aid and be physically
able to take part in a group exercise class. The deﬁn-
ition of visual impairment in the inclusion criteria is
deliberately broad and pragmatic, in order to apply ﬁnd-
ings to the whole spectrum of older participants who
may have vision difﬁculties and be at risk of falls. The
extent to which participants perceive their visual impair-
ment function and its impacts on daily living and any
changes to their perceived visual function after the inter-
ventions will be gathered within interviews and will
inform the methodology of the deﬁnitive trial.
Exclusion criteria
Those excluded will: (1) be unable to understand or
follow simple movement instructions in English; (2)
have acute or uncontrolled medical problems which
the participant’s GP considers would exclude them
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from undertaking the exercise programme (eg, uncon-
trolled heart disease, poorly controlled diabetes, acute
systemic illness, neurological problems, severe chronic
obstructive pulmonary disease), in addition to visual
impairment; (3) have conditions requiring a specialist
exercise programme, for example, uncontrolled epi-
lepsy, severe neurological disease or impairment,
unable to maintain a seated upright position or unable
to move independently indoors; and (4) be currently
involved in other falls prevention exercise programmes
(but not excluding walking programmes), investiga-
tional studies or trials.
Consent procedures
Signed or recorded verbal consent to participate in the
feasibility study (as appropriate for each VIOP partici-
pant) will be sought. If the VIOP is unable to sign the
consent form, verbal consent will be witnessed by a third
party, who will sign the witness section of the consent
form. The participant will speciﬁcally consent to: (1)
their GP being contacted regarding their medical ﬁtness
and being informed of their participation in the study;
and (2) being informed that they will not be recruited if
the GP considers the study to be a contraindication. The
right to refuse to participate without giving reasons will
Figure 1 Planned flow of participants throughout the VIOLET study. FaME, Falls Management Exercise; FES-I, Falls Efficacy
Scale International; FRAT, Falls Risk Assessment Tool; GP, general practitioner; HADS, Hospital Anxiety and Depression Scale;
TUG, Timed Up & Go test; VIOLET, Visually Impaired OLder people’s Exercise programme for falls prevenTion; WSAS, Work
and Social Adjustment Scale.
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be respected. It will also be explained that if it is felt the
intervention is or has the potential to cause signiﬁcant
harm to a participant, then for safety reasons, the partici-
pant involvement will be discontinued. The information
sheet and consent form for the study will be available
only in English. It was decided to exclude participants
who are unable to understand simple instructions in
English, as they would not be able to understand the
movement instructions given during the exercise sessions,
if randomised to the intervention arm of the study.
Randomisation
A blocked allocation (permuted random blocks of vari-
able length) system will be used to allocate participants
to the two groups (block size will not be disclosed to the
investigators) in a 1:1 ratio to intervention and control
groups. Randomisation will be stratiﬁed by centre.
Randomisation will be administered centrally via
Newcastle Clinical Trials Unit using a secure web-based
system. The principal investigator at site, or individual
with delegate authority, will access the web-based system.
Participant screening ID, initials and gender will be
entered into the web-based system, which will return the
allocation status. Participants will be informed by tele-
phone, of their allocated treatment group following
randomisation.
Study intervention
This two-centre randomised feasibility study incorporates
a control and an intervention condition.
Control arm
Those participants who are randomised to the control
group will receive no intervention but will be offered an
opportunity to take part in an equivalent falls prevention
exercise class, provided by local organisations currently
delivering these classes after the follow-up period.
Intervention arm
For the intervention arm, local qualiﬁed PSIs working at
each site will be trained by the research team members
with PSI expertise (DAS and SG) on adapting the exer-
cises for people with visual impairment, and following
recommendations from the stakeholder panels. The
PSIs will also receive visual impairment training from
one of the partner organisations for people with visual
impairment (Visibility).
The exercise class (the intervention) will run weekly
over 12 weeks, with each session lasting up to 1 hour
with an opportunity to socialise after the class. The exer-
cises will consist of individually tailored and targeted
training for dynamic balance, muscle and bone strength,
endurance, ﬂexibility, gait and functional skills, as well
as training to improve ‘righting’ or ‘correcting’ skills to
avoid a fall, backward chaining (getting down to and up
from the ﬂoor safely) and functional ﬂoor exercises. A
full description of the original exercise programming
and progression has been published.34
If required, participants will be provided with trans-
port (taxi) to and from the classes and can bring along
someone for support or bring a guide dog. Participants
will be also be advised to exercise at home for 30 min to
2 hours a week (using a progressive adapted standar-
dised home exercise programme that has been used in
other related studies31 33). Exercises will be provided in
a large print booklet, DVD or audio format and will
consist of speciﬁc chair-based exercises to improve
strength and ﬂexibility and standing exercises to
improve balance, power and bone health, already prac-
ticed within the class setting.
Data collection
Participants from the intervention and control groups will
be telephoned each week by the study team for 24 weeks
from baseline to record any adverse events, including falls
that occur during the intervention period and for
12 weeks following the intervention. These will be
assessed for duration, causality, expectedness, seriousness
and severity as will any adverse events reported by the
instructors within the exercise sessions. All non-serious
adverse events (SAEs) will be reported on the study elec-
tronic case report form (eCRF) with hard copies sent to
the Trial Management team within 4 weeks.
Table 1 offers a participant schedule of events.
Data management and monitoring
Data will be entered on to a secure, password-protected,
eCRF. As part of the data protection, conﬁdentiality and
anonymity requirements, all participants will be assigned
a unique individual identiﬁer. The database will be
managed by the Clinical Trials Unit. Access will be
limited to those deemed appropriate by the chief investi-
gator. The research assistants, in conjunction with the
database manager, and statisticians will carry out peri-
odic data quality checks. These will include double data
entry, snap shot analysis and query resolution. In rela-
tion to access to the ﬁnal study data set, anonymised
data will available from the chief investigator following
an ofﬁcial request and ratiﬁcation with the original
members of the TOC, which was introduced in the
‘Study governance’ section above.
This is a low-risk trial and major safety data are not
anticipated. The TOC will review any recorded SAEs
(eg, injurious falls and/or hospitalisation due to falls)
reported by the instructors within the exercise sessions
or reported on the falls diaries returned by participants.
The TOC will also monitor any trends in SAEs (eg,
more than a few falls in the exercise groups during the
exercise classes, or nearby, or a trend towards an
increase in injury) and bring the intervention to a close,
should this be deemed necessary. Overall the sponsor is
responsible for auditing study conduct.
Outcome measures
Standardised assessment instruments that have been used
in falls research and with older people will be
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administered and are listed in box 1.35–45 The primary
outcomes are related to feasibility, including the number
of participants that are recruited (recruitment), that
provide data at 24-week follow-up (retention), and attend
a substantial amount (9/12) of the group exercise ses-
sions if allocated to the intervention arm (adherence).
Data will be collected at baseline, 12 and 24 weeks
(box 1). The primary outcome of the future deﬁnitive
RCTwill be decided by the responsiveness to change, par-
ticipant burden and participant feedback from this study.
FoF is likely to be selected as the primary outcome
measure because while FoF is a common, debilitating
and a signiﬁcant predictor of a future fall particularly
among older people,46 successful management of FoF is
limited and unknown in VIOP. Recent reviews26 28 30 47
show that there is a lack of high-quality research, which
has FoF as a primary health outcome, provides guidance
on routine practice in this area and translates research
of FoF interventions to clinical settings. In addition,
there is limited health economic data about FoF inter-
ventions.28 29 Measuring the number of falls as a
primary outcome does not take into account the more
complex impacts of an intervention, which by reducing
FoF, may increase participants’ conﬁdence in their
ability to walk safely and continue to enjoy everyday
activities. Assessing FoF before and after the proposed
intervention captures participants’ perceptions of
change in their conﬁdence to continue with physical
and social activities. This in turn gives an indication of
their perceived quality of life and whether the negative
impacts of FoF, such as social isolation and risk of
further falls, have been reduced.
QUALITATIVE EVALUATION OF THE FEASIBILITY STUDY
Interviews with VIOP
In-depth qualitative interviews will be conducted with a
purposive sample of VIOP (∼3–5 from each site) to
explore reasons for taking part; factors that facilitate/
hinder them from participating in community-based falls
prevention exercise groups; and experiences of recruit-
ment and randomisation; views on outcome measures;
experiences of the adapted intervention. The interviews
with VIOP who complete the 12-week exercise pro-
gramme (the intervention) will be conducted within
2 weeks following the end of trial data collection. Any
VIOP who drops out during the intervention will also be
contacted within 2 weeks of dropping out and asked if
they would be willing to be interviewed by the researcher
about their experiences of the intervention and the
research and their reasons for dropping out.
The interviews will be conducted by the researchers in
the form of a brief telephone conversation with a set of
standardised questions, followed by, if willing, a face-to-face
interview in a safe location chosen by the interviewee, such
as their own home.
Interviews with postural stability instructors
Structured interviews will be conducted with the PSIs.
They will be interviewed at two points (before training
and at the end of the intervention) to explore their
(changing) perspectives on the provision of the inter-
vention to VIOP over the duration of the intervention.
ECONOMIC EVALUATION
A prospective economic evaluation will be rehearsed to
develop and reﬁne methods for a subsequent deﬁnitive
trial. The main focus will be on how to accurately iden-
tify, quantify and value the additional costs of delivering
the intervention and the potential resource implications
versus usual ‘activity’ and on what measurement tools
are appropriate to use with VIOP. The costing approach
will incorporate a broad analytical perspective (NHS,
social services and patient/carer costs), which will help
to detect cost-shifting between sectors. Resources used
in the exercise group will be identiﬁed in terms of
capital equipment, staff time and travel/time for
patients. Resource use in terms of out of pocket
expenses will also be explored for all participants in add-
ition to all treatment/care related to the intervention
and any falls that may occur during the study period.
This will be assessed retrospectively at the two follow-up
periods (12 weeks and 6 months) by piloting the use of
a falls resources/expenses form (to include informal
caregivers time). This will facilitate the development of a
reliable and valid tool to capture resource use.
Appropriate unit costs to be applied to resource use will
be identiﬁed. These will be sourced from a combination
of local costings and national databases. Methods to
value informal carer time will also be explored and
deﬁned, and all costs will be combined to rehearse the
methods for total health, social care and patient/carer
cost estimation in a subsequent deﬁnitive trial.
DATA ANALYSIS
As this is a feasibility study, a formal power calculation is
not appropriate. We would aim to obtain a minimum of
Box 1 Outcome assessment tools
Fear of falling (Short Falls Efficacy Scale—International (FES-I)35);
Activity avoidance (2 questions36);
Balance/falls risk (Timed Up & Go test (TUG)37);
Falls Risk Assessment Tool (FRAT38);
Number of falls (falls diary and weekly telephone call39);
Self-reported physical activity (Phone-FITT40);
Loneliness (6-Item Scale for Overall Emotional and Social
Loneliness41);
Anxiety and depression (Hospital Anxiety and Depression Scale
(14 items)42);
Work and Social Adjustment Scale (WSAS43);
Quality of life (EQ-5D-5L44 and ICEpop CAPability measure for
Older people (ICECAP-O)45);
Resource use via a health economic self-report service receipt
inventory;
Adherence to the group exercise programme (register) and home
exercise programme (self-reported).
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30 responses in each trial arm at 6-month follow-up to
estimate the critical parameters to the necessary degree
of precision.48 To provide feasibility data, a total of 80
community-living VIOP aged 60+ will be recruited from
NHS Low Vision Units and voluntary organisations to
allow for loss to follow-up. As recruitment and retention
rates are a relative unknown in this population, we will
seek advice from the stakeholder groups on how best to
reach them.
The main analyses will be descriptive, in order to
inform the design of a future deﬁnitive study. We will cal-
culate the numbers of eligible participants seen over the
recruitment period, and the resulting rates of recruit-
ment, compliance with randomisation, and data comple-
tion. We will also ascertain data completeness of the
instruments and any potential bias in the completion of
follow-up data to inform the choice of instruments in a
future trial. The majority of the outcome data will be
presented in simple descriptive tables presenting percen-
tages, means and SDs or ﬁve-number summary (as
appropriate), for each arm of the study. This informa-
tion will be used to inform the design, choice of primary
outcome, necessary sample size and approach to the
analysis of the future deﬁnitive trial.
There is a potential for clustering effects, particularly
class-based clustering in the intervention group and it
will be part of the function of the pilot trial to investi-
gate and estimate the size of any such effects. As this is a
feasibility study, the results will provide estimates of vari-
ability in key outcomes both within and between classes
and trial arms, which will be used to design a future
deﬁnitive trial. However, there will be very limited infor-
mation on the size of intraclass correlation coefﬁcient
(ICC) in a study with only two centres and two classes
per centre, and any estimates of ICC based on this pilot
trial will be very imprecise.
QUALITATIVE ANALYSIS
The interviews will be audio-taped and transcribed.
Framework analysis will be used to analyse the interviews
with the VIOP and PSIs.49 This has four non-linear inter-
connected stages: familiarisation of data, identifying a
thematic framework, indexing data into the framework,
developing charts from categories that are identiﬁed
within the framework and ﬁnally mapping and interpret-
ation. This will ﬁrst be carried out within each site inde-
pendent of the other and then combined with iterations
until consensus is reached. The main themes and cat-
egories of the analysis will be shared with participants
for member checking.
CRITERIA FOR SUCCESS
Following analysis of the qualitative interviews, the investi-
gators will document the practicality of the study design,
its impact on and acceptability to, both older people with
visual impairment and professionals, and the acceptabil-
ity and applicability of the outcome measures for older
person visually impaired (OPVI). The conclusions from
this discussion will inform the development of a deﬁnitive
RCTand an intervention manual.
The progression criteria to judge the feasibility of pro-
gressing to a full trial will be based on:
1. ≥50% of OPVI eligible for the study willing to be
recruited into the feasibility study;
2. ≥70% of the participants in the intervention arm
complete 9/12 group sessions in the exercise pro-
gramme (compliance);
3. Data collected on key outcomes at 6-month follow-up
for ≥70% of those recruited;
4. <10% of SAEs deemed due to the intervention itself.
ETHICAL APPROVAL
Glasgow Caledonian University was approved as a
non-NHS site with local ethics approval. In addition,
ethical approval was sought from the sponsoring institu-
tion: Northumbria University, and where needed the
Research and Development department of the NHS
Trust. As part of the ethical approval process, assurances
were given regarding the processes in place to assure
conﬁdentiality and anonymity. Personal data will be
regarded as strictly conﬁdential. To preserve anonymity,
any data leaving the site will identify participants using
their unique study identiﬁcation code only. The study
will comply with the Data Protection Act, 1998. All study
records and investigator site ﬁles will be kept at site in a
locked ﬁling cabinet with restricted access. No amend-
ment to the protocol will be made without consideration
and approval by the Trial Management Committee.
Authorisation for any approval will be sought from the
National Research Ethics Service (NRES) and NIHR.
Reports regarding the progress of the study will be sub-
mitted as required to NRES and National Institute for
Health Research (NIHR).
DISSEMINATION STRATEGY
Results will be published in an open access peer-
reviewed journal. The preliminary results from this feasi-
bility study will be shared and discussed with the original
stakeholder panel and the two charities involved. They
will shape the dissemination strategy but this is likely to
include articles and news items for vision charities and
older people organisations, falls services, and disability
and health policymakers.
DISCUSSION
The VIOLET study is designed to investigate the feasibil-
ity of a future deﬁnitive trial of the FaME exercise pro-
gramme adapted for VIOP. There are potential risks and
beneﬁts to introducing exercises to this population. FoF
in VIOP may exacerbate existing gait and balance difﬁ-
culties, further increasing the risk of falls. Recent
research has shown that older people are at increased
risk of falling following intensive endurance exercise
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bouts,50 through exercise-induced alterations in respir-
ation and muscular fatigue. It was noted that visual
impairment could increase exercise-induced changes to
postural control, and consequently the risk of falling.
This study will enable VIOP to collaborate with
researchers and instructors to draw on their expertise
and experience to adapt a commonly adopted exercise
programme, that is known to reduce falls risk in high-risk
frequent fallers31 and low-risk older adults,33 to their spe-
ciﬁc VI needs. This in turn may have positive impacts on
gait and balance, increase conﬁdence and lessen FoF.
This study will add to an emerging body of work that is
using FoF, as assessed by a widely validated cross-cultural
tool (Falls Efﬁcacy Scale International, FES-I), to address
the gap in knowledge of how to manage FoF successfully.
The feasibility study will develop a manualised interven-
tion, identify potential barriers and facilitating factors to
recruitment and retention, and test aspects of the trial
methodology to inform the design of a future deﬁnitive
trial of an adapted exercise programme for VIOP.
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